Published in Proc R Soc Med on April 01, 1977
Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis (2005) 2.21
Bacteremia due to Bifidobacterium, Eubacterium or Lactobacillus; twenty-one cases and review of the literature. Yale J Biol Med (1979) 1.44
Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient: organism identification, antibiotic therapy, and case report. J Clin Microbiol (1998) 0.98
Endocarditis caused by Lactobacillus. Postgrad Med J (1997) 0.75
A PATHOGENIC LACTOBACILLUS. J Pathol Bacteriol (1964) 1.28
Endocarditis caused by Lactobacillus plantarum. Ann Intern Med (1973) 1.25
TOXICITY OF LACTOBACILLUS CASEI. J Dent Res (1965) 1.13
[Apropos of a case of endocarditis due to a lactobacillus]. Ann Med Interne (Paris) (1969) 1.01
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis (2001) 2.69
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis (2004) 2.35
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med (1988) 1.72
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
Increased levels of antibodies to heat shock proteins with increasing age in Mrl/Mp-lpr/lpr mice. Br J Rheumatol (1995) 1.48
Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J Autoimmun (1991) 1.45
An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford) (2006) 1.42
Autoimmune diseases--at the molecular level. Immunol Today (1993) 1.42
The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis (2007) 1.37
A comparative analysis of disease-associated changes in the galactosylation of serum IgG. J Autoimmun (1989) 1.36
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol (1994) 1.35
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol (1992) 1.34
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.32
Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol (1999) 1.29
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27
The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol (1988) 1.23
Predictors of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum (1998) 1.22
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis (2008) 1.19
Prevalence of self-reported depression in patients with rheumatoid arthritis. Br J Rheumatol (1996) 1.17
Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. J Autoimmun (1993) 1.17
Analysis of B-cell epitopes of the Ro/SS-A autoantigen. Immunol Today (1999) 1.17
Association of Kikuchi-Fujimoto's disease with SLE. Rheumatology (Oxford) (2008) 1.12
Detection of cross reactive anti-DNA antibody idiotypes on tissue-bound immunoglobulins from skin biopsies of lupus patients. J Immunol (1985) 1.09
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken) (2012) 1.06
Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis Rheum (1999) 1.05
Studies of human polyclonal and monoclonal antibodies binding to lupus autoantigens and cross-reactive antigens. Rheumatology (Oxford) (2003) 1.04
The antibody repertoire of early human B cells. I. High frequency of autoreactivity and polyreactivity. Scand J Immunol (1990) 1.04
Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum (1991) 1.04
Race/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis Rheum (2005) 1.02
Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology. Lupus (2000) 1.01
Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum (2008) 1.01
Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. J Biol Chem (2000) 1.00
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus (2011) 1.00
Amyloidosis in the rheumatic diseases. Ann Rheum Dis (1989) 0.99
Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus (1993) 0.99
Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol (1996) 0.99
Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis. Rheumatol Int (1997) 0.98
Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus. Ann Rheum Dis (2005) 0.97
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus (2007) 0.97
Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort. Rheumatology (Oxford) (2009) 0.97
Hodgkin's lymphoma in systemic lupus erythematosus. Rheumatology (Oxford) (2007) 0.96
Expression of an interspecies idiotype in sera of SLE patients and their first-degree relatives. Clin Exp Immunol (1988) 0.95
Structural basis of the gp120 superantigen-binding site on human immunoglobulins. J Immunol (1998) 0.95
Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer (1994) 0.94
Factors associated with mood and mood disorders in SLE. Lupus (1995) 0.91
Sjögren's syndrome: a study of its neurological complications. Br J Rheumatol (1988) 0.90
Longitudinal analysis of antibodies to histones, Sm-D peptides and ubiquitin in the serum of patients with systemic lupus erythematosus, rheumatoid arthritis and tuberculosis. Clin Exp Rheumatol (1991) 0.90
Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature. Lupus (2008) 0.90
Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis. Br J Rheumatol (1991) 0.90
Breast cancer in systemic lupus erythematosus. Oncology (2013) 0.89
Duplex perception of cues for stop consonants: evidence for a phonetic mode. Percept Psychophys (1981) 0.89
Standardising joint assessment in rheumatoid arthritis. Clin Rheumatol (1996) 0.89
New therapies in systemic lupus erythematosus - trials, troubles and tribulations.... working towards a solution. Lupus (2008) 0.89
An analysis of joint replacement in patients with systemic lupus erythematosus. Lupus (2009) 0.88
DNA antibody idiotypes: an analysis of their clinical connections and origins. Int Rev Immunol (1990) 0.87
Fatigue in primary Sjögren's syndrome: is there a link with the fibromyalgia syndrome? Ann Rheum Dis (2000) 0.87
Human monoclonal antibodies to phenolic glycolipid-1 from leprosy patients cross react with poly(ADP-ribose), polynucleotides and tissue bound antigens. Autoimmunity (1988) 0.87
Apoptosis and antiphospholipid antibodies. Semin Arthritis Rheum (1998) 0.87
Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis (2011) 0.87
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus. Ann Rheum Dis (2008) 0.87
T cell receptor expression in Sjögren's syndrome. Ann Rheum Dis (1991) 0.87
Autoantibodies to 90 kD heat-shock protein in sera of breast cancer patients. Lancet (1995) 0.87
Cerebral dominance and reading disability: left visual field deficit in poor readers. Neuropsychologia (1975) 0.86
Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2014) 0.86
Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica. Lupus (2008) 0.85
DNA antibody idiotypes: a review of their genetic, clinical, and immunopathologic features. Semin Arthritis Rheum (1987) 0.85
Systematic analysis of sequences of anti-DNA antibodies--relevance to theories of origin and pathogenicity. Lupus (2002) 0.85
The overlap of systemic lupus erythematosus and sickle cell disease: report of two cases and a review of the literature. Lupus (2010) 0.85
Lung cancer in systemic lupus erythematosus. Lung Cancer (2007) 0.85
Naming names! Comment on the article by Smolen and Steiner. Arthritis Rheum (1999) 0.85
Elevation of the levels of SmB, B' and D proteins but not that of the La (SS-B) antigen during HSV infections. J Autoimmun (1989) 0.84
A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus. Clin Exp Immunol (1987) 0.84
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints. Ann Rheum Dis (2008) 0.83
A review of serological abnormalities in relatives of SLE patients. Lupus (1993) 0.82
Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvement. J Rheumatol (1987) 0.82
Autoantibodies, idiotypes, anti-idiotypes and autoimmunity. Acta Haematol (1986) 0.81
HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome. J Autoimmun (1994) 0.81
Production of human monoclonal antibodies to myeloperoxidase. Immunology (1992) 0.81
Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry results. Arthritis Care Res (Hoboken) (2014) 0.81
Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases. Lupus (2005) 0.81
SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis (2011) 0.80
"Coffee and": a way to treat the untreatable. Am J Psychiatry (1971) 0.80
Does it take sugar? A clinical role for measuring the glycosylation of IgG? Ann Rheum Dis (1995) 0.80
Binding of anti-DNA antibodies to oxidatively damaged DNA in spouses and relatives of patients with systemic lupus erythematosus. Immunol Lett (1994) 0.80
Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravis. Autoimmunity (1995) 0.80
Autoantibodies against a nuclear 56 kDa protein: a marker for inflammatory muscle disease. J Autoimmun (1989) 0.80
Lupus in the family--analysis of a cohort followed from 1978 to 1999. Lupus (2001) 0.79
Atherosclerosis and lupus. Rheumatology (Oxford) (2004) 0.79
Endorsement and memory bias of self-referential pain stimuli in depressed pain patients. Br J Clin Psychol (1995) 0.79
Rheumatoid factor: primary or secondary event in the pathogenesis of RA? Int Arch Allergy Immunol (1993) 0.79